Validation of the Prognosis for Prolonged Ventilation (ProVent) score in patients receiving 14 days of mechanical ventilation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Won-Young | - |
dc.contributor.author | Jo, Eun-Jung | - |
dc.contributor.author | Eom, Jung Seop | - |
dc.contributor.author | Mok, Jeongha | - |
dc.contributor.author | Kim, Mi-Hyun | - |
dc.contributor.author | Kim, Ki Uk | - |
dc.contributor.author | Park, Hye-Kyung | - |
dc.contributor.author | Lee, Min Ki | - |
dc.contributor.author | Lee, Kwangha | - |
dc.date.accessioned | 2024-01-08T06:58:15Z | - |
dc.date.available | 2024-01-08T06:58:15Z | - |
dc.date.issued | 2018-04 | - |
dc.identifier.issn | 0883-9441 | - |
dc.identifier.issn | 1557-8615 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/69445 | - |
dc.description.abstract | Purpose: To evaluate the performance of the Prognosis for Prolonged Ventilation (ProVent) 14 score in patients requiring prolonged mechanical ventilation (PMV). Materials and methods: Data were obtained from 366 patients receiving at least 14 days of MV between January 2011 and December 2015 at a university-affiliated tertiary care hospital in Korea. ProVent 14 scores were assessed using the six standard variables. Model discrimination was assessed with the area under the receiver operating characteristic curve. Kaplan-Meier estimates were stratified according to the ProVent 14 score to predict 1-year survival. Results: The median age of the study group was 62 years (range, 50-72 years); 65% were male, and medical patients comprised 66% of the group. Overall mortality at 1 year was 43%. For ProVent 14 scores ranging from 0 to >= 4, 1-year mortality rates were 7%, 22%, 41%, 52%, and 75%, respectively (log-rank test, P < 0.001). The area under the receiver operating characteristic curve of the ProVent 14 score predicting 1-year mortality was 0.74 (95% confidence interval, 0.69-0.78). Conclusions: The ProVent 14 score accurately identified patients receiving PMV with a high 1-year mortality risk. Further validation in a larger sample is required. (C) 2017 Elsevier Inc. All rights reserved. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | W B SAUNDERS CO-ELSEVIER INC | - |
dc.title | Validation of the Prognosis for Prolonged Ventilation (ProVent) score in patients receiving 14 days of mechanical ventilation | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.jcrc.2017.11.029 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CRITICAL CARE, v.44, pp 249 - 254 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000426565300046 | - |
dc.identifier.scopusid | 2-s2.0-85042495480 | - |
dc.citation.endPage | 254 | - |
dc.citation.startPage | 249 | - |
dc.citation.title | JOURNAL OF CRITICAL CARE | - |
dc.citation.volume | 44 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | Mortality | - |
dc.subject.keywordAuthor | Prognosis | - |
dc.subject.keywordAuthor | Respiration, artificial | - |
dc.subject.keywordAuthor | Risk | - |
dc.subject.keywordPlus | MORTALITY PREDICTION MODEL | - |
dc.subject.keywordPlus | CRITICALLY-ILL PATIENTS | - |
dc.subject.keywordPlus | INTENSIVE-CARE UNITS | - |
dc.subject.keywordPlus | CRITICAL ILLNESS | - |
dc.subject.keywordPlus | SEVERITY | - |
dc.subject.keywordPlus | FAILURE | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Critical Care Medicine | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.